Patents by Inventor David Bradley Woodward

David Bradley Woodward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic uses of dulaglutide
    Patent number: 11890325
    Abstract: The present invention relates to methods for reducing the risk of major adverse cardiovascular events in type 2 diabetes mellitus (T2DM) patients with multiple cardiovascular risk factors without established cardiovascular disease or with established cardiovascular disease comprising administering the glucagon like peptide-1 (GLP-1) receptor agonist dulaglutide.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: February 6, 2024
    Assignee: ELI LILLY AND COMPANY
    Inventors: Jeffrey S. Riesmeyer, David Bradley Woodward
  • Methods of using and compositions containing dulaglutide
    Patent number: 11576950
    Abstract: The present invention relates to methods of using new doses of dulaglutide and compositions containing such higher doses of dulaglutide.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 14, 2023
    Assignee: Eli Lilly and Company
    Inventors: David Andrew Cox, Zvonko Milicevic, Lai San Tham, David Bradley Woodward
  • Therapeutic Uses of Dulaglutide
    Publication number: 20220202908
    Abstract: The present invention relates to methods for reducing the risk of major adverse cardiovascular events in type 2 diabetes mellitus (T2DM) patients with multiple cardiovascular risk factors without established cardiovascular disease or with established cardiovascular disease comprising administering the glucagon like peptide-1 (GLP-1) receptor agonist dulaglutide.
    Type: Application
    Filed: November 4, 2019
    Publication date: June 30, 2022
    Inventors: Jeffrey S. Riesmeyer, David Bradley Woodward
  • METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE
    Publication number: 20200330558
    Abstract: The present invention relates to methods of using new doses of dulaglutide and compositions containing such higher doses of dulaglutide.
    Type: Application
    Filed: November 13, 2018
    Publication date: October 22, 2020
    Inventors: David Andrew Cox, Zvonko Milicevic, Lai San Tham, Andrew Gordon Werner, David Bradley Woodward